Date: October 15, 2026
Regulatory Compliance Disclosure
Ajooni Biotech Limited submitted a mandatory compliance certificate to the National Stock Exchange of India Ltd pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
The certificate, issued by the company's Registrar and Transfer Agent (RTA) Cameo Corporate Services Limited (Ref: CAM/AJO/74(5)/Q4/2026) and dated October 6, 2026, confirms compliance with dematerialization procedures for the quarter ended September 30, 2026.
Certificate Contents
The RTA certificate confirms that:
- Securities received from depository participants for dematerialization during Q2 FY2027 (quarter ended September 30, 2026) were confirmed (accepted/rejected) to the depositories
- Securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed
- Security certificates received for dematerialization have been mutilated and cancelled after due verification by the depository participant
- The name of the depositories has been substituted in the register of members as the registered owner within the stipulated time limit under the regulations